Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Full STEP: Step-wise vs. Basal-bolus Insulin Aspart in Type 2 Diabetes
NCT01165684Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- Oct 2010
- Primary completion
- Apr 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 7
01
Overview
A Phase 4 trial of insulin aspart in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Oct 2010; status: completed.
02
Drugs
insulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01165684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01165684.